Scarica l'app Stockscreener
228.40
1.53%
-3.55
Pre-mercato:
228.00
-0.40
-0.18%
Natera Inc Borsa (NTRA) Ultime notizie
NeoGenomics (NEO): Assessing Valuation After Legal Win Over Natera and New Oncology Data Releases - simplywall.st
Jefferies raises Natera stock price target to $275 on oncology growth - Investing.com India
Barclays Raises Natera (NTRA) Price Target to $270 | NTRA Stock News - GuruFocus
NTRA: JP Morgan Raises Price Target to $260 with Overweight Rati - GuruFocus
Natera (NASDAQ:NTRA) Given New $260.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Natera dismisses appeal in patent case against NeoGenomics - Investing.com India
Natera dismisses appeal in patent case against NeoGenomics By Investing.com - Investing.com Canada
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litig - pharmiweb.com
NeoGenomics Says Natera Withdraws Appeal in Patent Case - marketscreener.com
Neogenomics announces that Natera has voluntarily withdrawn its appeal in ongoing RaDaR patent litigation - marketscreener.com
Neogenomics Announces That Natera Has Voluntarily Withdrawn Its Appeal In Ongoing RaDaR Patent Litigation - TradingView — Track All Markets
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation - Business Wire
Marex Group plc Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Castleark Management LLC Has $5.87 Million Stake in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA): Assessing Valuation After Strong Multi‑Year Share Price Rally - simplywall.st
Holocene Advisors LP Boosts Stake in Natera, Inc. $NTRA - MarketBeat
Fullerton Fund Management Co Ltd. Has $1.05 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Nikko Asset Management Americas Inc. - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Engineers Gate Manager LP Sells 30,042 Shares of Natera, Inc. $NTRA - MarketBeat
GCM Grosvenor Holdings LLC Sells 6,475 Shares of Natera, Inc. $NTRA - MarketBeat
Gilder Gagnon Howe & Co. LLC Decreases Stake in Natera, Inc. $NTRA - MarketBeat
Bellevue Group AG Raises Stock Position in Natera, Inc. $NTRA - MarketBeat
AQR Capital Management LLC Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Exelixis (EXEL) and Natera (NTRA) - The Globe and Mail
Caption Management LLC Takes Position in Natera, Inc. $NTRA - MarketBeat
Natera (NTRA) Joins Phase II Breast Cancer Study with Innovative DNA Testing - GuruFocus
Maverick Capital Ltd. Reduces Position in Natera, Inc. $NTRA - MarketBeat
Natera and MEDSIR to Collaborate on the MiRaDoR Trial in Breast Cancer - Yahoo Finance
Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know - MSN
Natera Completes Acquisition Of Foresight Diagnostics For Up To $450 Million - Pulse 2.0
Natera New Test Data Could Change How Doctors Manage Breast CancerNatera (NASDAQ:NTRA) - Benzinga
Is It Too Late to Consider Natera After a 511% Three Year Surge? - simplywall.st
Natera stock rating reiterated at Buy by TD Cowen on solid momentum - Investing.com India
Is It Too Late To Consider Natera After Its Recent 12.8% Price Surge? - Yahoo Finance
California Public Employees Retirement System Purchases 29,296 Shares of Natera, Inc. $NTRA - MarketBeat
Frontier Capital Management Co. LLC Has $65.04 Million Position in Natera, Inc. $NTRA - MarketBeat
Baird Financial Group Inc. Has $4.50 Million Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by Amundi - MarketBeat
Natera (NTRA) Unveils Promising Results from Phase III Breast Ca - GuruFocus
Natera (NASDAQ: NTRA) PALLAS: Signatera MRD‑positive group shows 13.4‑21.5 hazard ratios - Stock Titan
Phase III PALLAS Study Shows Signatera™ MRD Testing Provides Powerful Post‑Surgical Prognostic Information in Patients with High and Intermediate Risk HR+/HER2‑ Breast Cancer - Yahoo Finance
Natera acquires Foresight Diagnostics for up to $450M - MedTech Dive
Preimplantation Genetics Diagnosis Market size to exceed - openPR.com
Natera, Inc. $NTRA Stake Lowered by Blue Water Life Science Advisors LP - MarketBeat
Cerity Partners LLC Boosts Holdings in Natera, Inc. $NTRA - MarketBeat
Rowan Chapman Sells 4,366 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera director Chapman sells shares for $1.06 million By Investing.com - Investing.com South Africa
Natera director Chapman sells shares for $1.06 million - Investing.com
What's Driving the Market Sentiment Around Natera Inc? - Benzinga
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Makes New $1.24 Million Investment in Natera, Inc. $NTRA - MarketBeat
Natera Highlights New Findings in Lymphoma at the ASH Annual Meeting - marketscreener.com
Wilson Sonsini Advises Foresight Diagnostics on Acquisition by Natera - Wilson Sonsini
Natera's (NTRA) Buy Rating Reiterated at Canaccord Genuity Group - MarketBeat
Natera, Inc. Stock (NTRA) Opinions on Foresight Acquisition and Signatera Data - Quiver Quantitative
BTIG Research Boosts Natera (NASDAQ:NTRA) Price Target to $260.00 - MarketBeat
Natera stock rises after Canaccord reiterates Buy rating following Foresight acquisition - Investing.com UK
Guggenheim Capital LLC Sells 4,628 Shares of Natera, Inc. $NTRA - MarketBeat
Natera purchases Foresight Diagnostics - Yahoo Finance
Natera Makes High-Conviction Moves to Seize the Lucrative Oncology Frontier; Will It Succeed? - Smartkarma
Federated Hermes Inc. Has $129.71 Million Position in Natera, Inc. $NTRA - MarketBeat
Jump Financial LLC Purchases 18,821 Shares of Natera, Inc. $NTRA - MarketBeat
Invesco Ltd. Sells 165,294 Shares of Natera, Inc. $NTRA - MarketBeat
Natera Acquires Foresight Diagnostics - Oncodaily
Natera Acquires Foresight Diagnostics for $275 Million - The Globe and Mail
1.35%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):